First Bank & Trust Exagen Inc. Transaction History

First Bank & Trust

$467 Million
Q1 2024

A detailed history of First Bank & Trust transactions in Exagen Inc. stock. As of the latest transaction made, First Bank & Trust holds 13,518 shares of XGN stock, worth $24,062. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,518

Previous 13,518 -0.0%

Holding current value

$24,062

Previous $26,000 19.23%

% of portfolio

0.0%

Previous 0.01%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 12, 2024	SELL	$1.45 - $2.39 $1,242 - $2,048	-857 Reduced 5.96%	13,518 $26,000
Q2 2023 Jul 12, 2023	SELL	$2.36 - $3.48 $5,706 - $8,414	-2,418 Reduced 14.4%	14,375 $41,000
Q1 2023 Apr 25, 2023	SELL	$2.23 - $2.9 $11,509 - $14,966	-5,161 Reduced 23.51%	16,793 $40,000
Q4 2022 Jan 27, 2023	SELL	$2.1 - $3.4 $10,195 - $16,507	-4,855 Reduced 18.11%	21,954 $53,000
Q3 2022 Oct 28, 2022	BUY	$3.43 - $8.68 $12,461 - $31,534	3,633 Added 15.68%	26,809 $72,000

Q2 2022 Jul 22, 2022	BUY	$4.18 - $7.74 $31,028 - $57,454	7,423 Added 47.12%	23,176 $133,000
Q1 2022 Apr 29, 2022	BUY	$7.12 - $11.06 $22,470 - $34,905	3,156 Added 25.05%	15,753 $127,000
Q4 2021 Feb 01, 2022	BUY	$8.97 - $14.08 $35,745 - $56,108	3,985 Added 46.27%	12,597 $147,000
Q3 2021 Oct 18, 2021	BUY	$10.25 - $15.21 $4,294 - $6,372	419 Added 5.11%	8,612 $117,000
Q2 2021 Aug 10, 2021	BUY	$12.4 - $17.92 $52,055 - $75,228	4,198 Added 105.08%	8,193 $123,000
Q1 2021 Apr 14, 2021	BUY	$13.9 - $22.0 $55,530 - $87,890	3,995 New	3,995 $70,000

Others Institutions Holding XGN

# of Institutions

Shares Held

6.21M

Call Options Held

1.6K

Put Options Held

4.1K

View Full List

About EXAGEN INC.

Ticker XGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 16,260,400
Market Cap $28.9M
Description
Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...

More about XGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on First Bank & Trust with notifications on news.

Account